Drug Supply in Biological Specimens from Emergency Departments
Closed Posted
- Opportunity number
- EDS-EDS-25-001
- Agency
-
Office of the National Drug Control Policy
Executive Office of the President
- Applications due
- Award size
- Up to $400,000
Opportunity facts
- Assistance listings
-
- 95.007 Research and Data Analysis
- Funding instrument
- Cooperative Agreement
- Category
-
- Health
- Eligible applicants
-
- Higher Education Inst. (Public)
- 501(c)(3) Nonprofits
- Other
- Higher Education Inst. (Private)
- Points of contact
-
- Grants.gov Contact Center contact@grants.gov (800) 518-4726
- Full announcement
Opportunity details come from Grants.gov. Updated .
About this opportunity
The Executive Office of the President's Office of the National Drug Control Policy (ONDCP) is seeking research proposals for a cooperative agreement focused on drug supply surveillance in biological specimens from emergency departments. The primary objective is to build local and national drug consumption surveillance capabilities, identify gaps in existing drug testing protocols, and facilitate information exchange across public health and public safety organizations. Applicants must demonstrate expert knowledge and extensive experience in conducting drug research and data analysis, with a clear ability to support the agency's goal of informing drug policy formulation and assessment. Qualifying organizations include public and private higher education institutions, 501(c)(3) nonprofits, and other research-focused entities. The grant opportunity was posted on August 14, 2025, with proposals due by September 5, 2025, under the Research and Data Analysis Federal Grant Program (CFDA 95.007).
The cooperative agreement will be available for an initial 12-month performance period, with potential extensions possible. While specific award amounts are not precisely defined, similar recent grants in this program have ranged from $100,000 to $3,000,000. The place of performance is nationwide, reflecting the program's goal of developing comprehensive drug consumption surveillance strategies. Successful grantees must maintain detailed financial records related to the grant and retain these records for three years following the award. Upon ONDCP approval, a grant letter with specific conditions will be issued to the selected applicant.
Synopsis
This research project will help build local and national drug consumption surveillance identify gaps in existing drug testing protocols facilitate information exchange across public health and public safety organizations and help coordinate an informed response to address the drug crisis.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity